Follow
SpectraCure AB
Nasdaq First North GM (Sweden)
SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.
Sector:
HEALTH CARE
>
Medical Devices
Healthcare
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
SPEC
SE0007158118
Nasdaq First North GM
Sweden (SE)
Details of share in SpectraCure AB with ticker SPEC
Status
Active
Order book id
4138
Amount of instruments
97 131 608
Par value
0.1000
Currency
SEK
Segment
First North Premier
First trading date
01 Jul 2015
Type
Price
Pre-money valuation
Time
Files
IPO
2.40 SEK
39.4M SEK
25 May - 12 Jun 2015
IPO in SpectraCure AB
Type
Price
Pre-money valuation
Time
Files
Targeted issue
1.35 SEK
33M SEK
27 Nov 2015
Share issue in SpectraCure AB
Type
Price
Pre-money valuation
Time
Files
Exercise
3.00 SEK
01 Sep - 30 Sep 2016
Option exercise terms for SPEC TO 1
Type
Price
Pre-money valuation
Time
Files
Rights issue
0.80 SEK
24M SEK
02 Dec - 16 Dec 2016
Share issue in SpectraCure AB
Type
Price
Pre-money valuation
Time
Files
Exercise
1.00 SEK
31 Jan - 28 Feb 2018
Option exercise terms for SPEC TO 2
Type
Price
Pre-money valuation
Time
Files
Rights issue
5.25 SEK
366.8M SEK
12 Oct - 30 Oct 2018
Share issue in SpectraCure AB
Type
Price
Pre-money valuation
Time
Files
Market move
04 Dec 2018
Listing of SpectraCure AB on Nasdaq First North GM
Type
Price
Pre-money valuation
Time
Files
Exercise
6.50 SEK
01 Nov - 29 Nov 2019
Option exercise terms for SPEC TO3
Type
Price
Pre-money valuation
Time
Files
Rights issue
16.00 SEK
1.4B SEK
05 Jun - 23 Jun 2020
Share issue in SpectraCure AB
Type
Price
Pre-money valuation
Time
Files
Remuneration issue
16.00 SEK
1.4B SEK
20 Jul 2020
Share issue in SpectraCure AB
Type
Ticker
ISIN
Market
OPTION
SPEC TO4
SE0014428868
Nasdaq First North GM
Sweden (SE)
Details of option in SpectraCure AB with ticker SPEC TO4
Status
Active
Order book id
Amount of instruments
Currency
SEK
First trading date
10 Aug 2020
Terms
Two (2) warrants of the TO4 series give during the period from 1 September 2021 to 30 September 2021 the right to subscribe for one (1) new share in SpectraCure at a price of SEK 20.75 per share.
Type
Price
Pre-money valuation
Time
Files
Exercise
20.75 SEK
01 Sep - 30 Sep 2021
Option exercise terms for SPEC TO4
Type
Ticker
ISIN
Market
SHARE
SPEC
SE0007158118
Nasdaq First North GM
Sweden (SE)
Details of share in SpectraCure AB with ticker SPEC
Status
Active
Order book id
4138
Amount of instruments
97 131 608
Par value
0.1000
Currency
SEK
Segment
First North Premier
First trading date
01 Jul 2015
Type
Price
Pre-money valuation
Time
Files
IPO
2.40 SEK
39.4M SEK
25 May - 12 Jun 2015
IPO in SpectraCure AB
Type
Price
Pre-money valuation
Time
Files
Targeted issue
1.35 SEK
33M SEK
27 Nov 2015
Share issue in SpectraCure AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
0.80 SEK
24M SEK
02 Dec - 16 Dec 2016
Share issue in SpectraCure AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
5.25 SEK
366.8M SEK
12 Oct - 30 Oct 2018
Share issue in SpectraCure AB
Type
Price
Pre-money valuation
Time
Files
Market move
04 Dec 2018
Listing of SpectraCure AB on Nasdaq First North GM
Type
Price
Pre-money valuation
Time
Files
Rights issue
16.00 SEK
1.4B SEK
05 Jun - 23 Jun 2020
Share issue in SpectraCure AB
Type
Price
Pre-money valuation
Time
Files
Remuneration issue
16.00 SEK
1.4B SEK
20 Jul 2020
Share issue in SpectraCure AB
Type
Ticker
ISIN
Market
OPTION
SPEC TO 1
SE0007158126
Nasdaq First North GM
Sweden (SE)
Details of option in SpectraCure AB with ticker SPEC TO 1
Status
Archived
Order book id
Amount of instruments
Currency
SEK
Trading period
29 Jun 2015 - 28 Sep 2016
Terms
Two (2) subscription options (TO 1) entitles the owner to subscribe for one (1) share.
Type
Price
Pre-money valuation
Time
Files
Exercise
3.00 SEK
01 Sep - 30 Sep 2016
Option exercise terms for SPEC TO 1
Type
Ticker
ISIN
Market
OPTION
SPEC TO 2
SE0009294853
Nasdaq First North GM
Sweden (SE)
Details of option in SpectraCure AB with ticker SPEC TO 2
Status
Archived
Order book id
Amount of instruments
Currency
SEK
Trading period
27 Jan 2017 - 26 Feb 2018
Terms
Two (2) Series 2 warrants (TO2) entitles the holder to subscribe for one (1) share in the Company.
Type
Price
Pre-money valuation
Time
Files
Exercise
1.00 SEK
31 Jan - 28 Feb 2018
Option exercise terms for SPEC TO 2
Type
Ticker
ISIN
Market
OPTION
SPEC TO3
SE0011762350
Nasdaq First North GM
Sweden (SE)
Details of option in SpectraCure AB with ticker SPEC TO3
Status
Archived
Order book id
164588
Amount of instruments
11 799 770
Currency
SEK
Segment
First North Premier
Trading period
05 Dec 2018 - 27 Nov 2019
Terms
Two (2) warrants entitles the holder to subscribe for one (1) new share.
Type
Price
Pre-money valuation
Time
Files
Exercise
6.50 SEK
01 Nov - 29 Nov 2019
Option exercise terms for SPEC TO3
Type
Ticker
ISIN
Market
OPTION
SPEC TO4
SE0014428868
Nasdaq First North GM
Sweden (SE)
Details of option in SpectraCure AB with ticker SPEC TO4
Status
Active
Order book id
Amount of instruments
Currency
SEK
First trading date
10 Aug 2020
Terms
Two (2) warrants of the TO4 series give during the period from 1 September 2021 to 30 September 2021 the right to subscribe for one (1) new share in SpectraCure at a price of SEK 20.75 per share.
Type
Price
Pre-money valuation
Time
Files
Exercise
20.75 SEK
01 Sep - 30 Sep 2021
Option exercise terms for SPEC TO4
People
Masoud Khayyami
CEO
Ingemar Kihlström
Chairman of the board
Stefan Andersson Engels
Board member
Masoud Khayyami
Board member
Ingemar Kihlström
Board member
Katarina Svanberg
Board member
Sune Svanberg
Board member
Hans Bornefalk
Board member
Company Details
Sector
HEALTH CARE

Address
Gasverksgatan 1
Zip code
222 29
City/district
Lund
Country
Sweden (SE)
Registration number
556642-1011
LEI code
549300U3BMSZ5VGYC283
First trade date
29 Jun 2015
Registration date
08 Oct 2017
Short name
SpectraCure

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date